GlassScriptPhysician profile
Ethan C Hansen
NPI 1447486899
$412.53
in general payments reported to CMS, 2019-2025
7 companies · $22.80 in 2025
The $22.80 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $16.34 · 2021: $60.13 · 2022: $41.94 · 2023: $60.90 · 2024: $85.87 · 2025: $22.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $169.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $162.39 | 2021-2025 | Abre, Mvp |
| Penumbra, INC. | $140.60 | 2019-2024 | Red 72 |
| Advanced Critical Devices, INC. | $31.95 | 2023 | |
| Bard Peripheral Vascular, INC. | $23.21 | 2024 | |
| Novo Nordisk INC | $22.84 | 2024 | Wegovy |
| Medtronic Vascular, INC. | $16.34 | 2020 | |
| Amgen INC. | $15.20 | 2023 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ethan Hansen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.